Medical Cannabis for Insomnia in the UK in 2025 – Evidence, Access, and Important Considerations
Insomnia affects around 10% of UK adults, causing significant distress, impaired daily functioning, and increased risk of other health issues […]
Sleep & Insomnia explores the potential role of medical cannabis and cannabis-based products for medicinal use (CBPMs) in managing sleep disorders in the UK in 2025. Articles in this category cover current evidence, private clinic access, CBD vs THC considerations, risks, legal notes, and important disclaimers for insomnia, sleep latency issues, and related conditions. All content is educational only — not medical advice. Always consult a specialist doctor.
Insomnia affects around 10% of UK adults, causing significant distress, impaired daily functioning, and increased risk of other health issues […]